Geographic Atrophy

Latest News

Q&A: Priya S. Vakharia, MD, shares insight into the Phase 2 ARCHER trial for GA
Q&A: Priya S. Vakharia, MD, shares insight into the Phase 2 ARCHER trial for GA

May 30th 2025

Vakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and future directions in ophthalmology.

Post hoc analysis of GATHER1 and GATHER2 data
Post hoc analysis of GATHER1 and GATHER2 data

May 30th 2025

Diffuse-trickling FAF pattern linked to greater ellipsoidal zone loss in GA
Diffuse-trickling FAF pattern linked to greater ellipsoidal zone loss in GA

May 22nd 2025

FDA grants Breakthrough Therapy Designation for Tinlarebant
FDA grants Breakthrough Therapy Designation for Tinlarebant

May 21st 2025

Video Series
Video Interviews
Podcasts
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
Innovation Series: A stem cell patch for treating advanced dry AMD
Ehsan Sadri, MD,  leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

More News

© 2025 MJH Life Sciences

All rights reserved.